Perceptions and opinions of country’s hospital pharmacists on bio-similar drugs

Postgraduate Thesis uoadl:2790623 455 Read counter

Unit:
ΠΜΣ Σχεδιασμός και Διοίκηση Υπηρεσιών Υγείας
Library of the School of Health Sciences
Deposit date:
2018-09-18
Year:
2018
Author:
Spiridaki Aikaterini
Supervisors info:
Τούντας Γιάννης, Καθηγητής, Ιατρική, ΕΚΠΑ
Σουλιώτης Κυριάκος, Αναπληρωτής Καθηγητής, Κοινωνικών Επιστημών, ΠΠ
Καντζανού Μαρία, Επίκουρη Καθηγήτρια, Ιατρική, ΕΚΠΑ
Original Title:
Αντιλήψεις και απόψεις των νοσοκομειακών φαρμακοποιών της χώρας για τα βιοομοειδή φάρμακα
Languages:
Greek
Translated title:
Perceptions and opinions of country’s hospital pharmacists
on bio-similar drugs
Summary:
The dynamic emergence of bio-similar medicines in Europe in 2006 along with the approval of the first bio-similar by the European Medicines Agency (EMA) has created increased expectations both for the access of patients in specialized treatments and for the economic sustainability of health systems.
Due to the imminent expiration of the exclusive rights (patents) of many on patent biological medicines and the entry of new bio-similar species into the pharmaceutical market, the attitudes and beliefs of the country's hospital pharmacists for bio-similar drugs are of particular interest. The purpose of this research is to investigate the perceptions and opinions of hospital pharmacists on bio-similar drugs. Pharmacists can play a significant role in promoting and communicating reliable information between the medical community and patients, ensuring the proper and safe use of bio-similar drugs.
Research has shown that the majority of pharmacists, although not feeling sufficiently informed, are aware that bio-similar medicines are similar to reference medicines in terms of safety and efficacy. Bio-similar feedback information mainly comes from the internet and scientific conferences / meetings, while the main barriers to wider use of bio-similar drugs are uncertainty about substitution and interchangeability and patients' desire to be treated with reference biological drugs.
The findings of this research may help identify needs and design educational actions to enhance the self-confidence of pharmacists in promoting safe use of bio-similar drugs.
Main subject category:
Health Sciences
Keywords:
Bio-similar, Biopharmaceuticals, Interchangeability and substitution, Traceability and pharmacovigilance, Cost savings in national health system
Index:
No
Number of index pages:
0
Contains images:
Yes
Number of references:
87
Number of pages:
74
SPIRIDAKI AIKATERINI-master.pdf (1 MB) Open in new window